In addition, whether to use bDMARDs in the treatment of children with ERA requires comprehensive clinical symptoms, inflammatory indicators (CRP, ESR, TNF-α, etc.)and MRI examination to evaluate the children's condition, to formulate the best treatment strategy. Here, CRP is linked to enthesitis-related juvenile idiopathic arthritis.